Who owns the GANDEEVA THERAPEUTICS trademark?

The GANDEEVA THERAPEUTICS trademark is owned by Gandeeva Therapeutics, Inc..

What class is the GANDEEVA THERAPEUTICS trademark registered in?

The GANDEEVA THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for GANDEEVA THERAPEUTICS?

The USPTO serial number for GANDEEVA THERAPEUTICS is 97981258.

What is the registration number for GANDEEVA THERAPEUTICS?

GANDEEVA THERAPEUTICS is registered under USPTO registration number 8223464.

GAN

USPTO Trademark Record

REGISTERED

GANDEEVA THERAPEUTICS

SN 97981258·Reg 8223464·Filed Jul 26, 2022

Owner Gandeeva Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

GANDEEVA THERAPEUTICS (Serial No. 97981258), Registration No. 8223464, is a registered US trademark filed on Jul 26, 2022 by Gandeeva Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

early section 8: April 21, 2032

Mark Intelligence

GANDEEVA THERAPEUTICS (Reg. #8223464) is a registered US trademark that has been protecting its owner, Gandeeva Therapeutics, Inc., since 2022. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 26, 2022

SERIAL

97981258

REG#

8223464

REGISTERED

Apr 21, 2026

Owner

Applicant

Gandeeva Therapeutics, Inc.

Entity

Corporation

State

Address

600 Stewart St., Suite 300, Seattle, WA, 98101

Country

Attorney

NameJessica L. Rothstein

Law firm

Jessica L. Rothstein GOODWIN PROCTER LLP

Docket

140846347327

Address

620 EIGHTH AVENUE, NEW YORK, NY 10018, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJul 26, 2022

Serial Number97981258

Registration No.8223464

Registration DateApr 21, 2026

Status DateApr 21, 2026

Published for OppositionAug 01, 2023

Mark TypeDesign with words

Attorney Docket140846347327

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jan 17, 2025

First use in commerce: Jan 17, 2025

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Jan 17, 2025

First use in commerce: Jan 17, 2025

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

48 events

REGISTERED-PRINCIPAL REGISTER

Apr 21, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 21, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 29, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 29, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

DIVISIONAL PROCESSING COMPLETE

Mar 05, 2026

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Mar 05, 2026

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 04, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 04, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 GRANTED

Mar 03, 2026

SOU EXTENSION 4 GRANTED

TEAS STATEMENT OF USE RECEIVED

Sep 26, 2025

TEAS STATEMENT OF USE RECEIVED

DIVISIONAL REQUEST RECEIVED

Sep 26, 2025

DIVISIONAL REQUEST RECEIVED

SOU TEAS EXTENSION RECEIVED

Sep 26, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Sep 26, 2025

SOU EXTENSION 4 FILED

TEAS REQUEST TO DIVIDE RECEIVED

Sep 26, 2025

TEAS REQUEST TO DIVIDE RECEIVED

USE AMENDMENT FILED

Sep 26, 2025

USE AMENDMENT FILED

SOU EXTENSION 3 FILED

Mar 25, 2025

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Mar 25, 2025

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 25, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Mar 24, 2025

SOU TEAS EXTENSION RECEIVED

Aug 22, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Aug 22, 2024

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Aug 22, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 22, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 20, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Mar 19, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Mar 19, 2024

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Mar 19, 2024

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 26, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 01, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 01, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 12, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jun 22, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jun 22, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jun 22, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jun 22, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 22, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Jun 12, 2023

PREVIOUS ALLOWANCE COUNT WITHDRAWN

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 07, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

WITHDRAWN FROM PUB - OG REVIEW QUERY

Jun 07, 2023

WITHDRAWN FROM PUB - OG REVIEW QUERY

EXAMINERS AMENDMENT -WRITTEN

May 22, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 22, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 22, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 22, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 22, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

May 11, 2023

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 18, 2022

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 17, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 29, 2022

NEW APPLICATION ENTERED

GANDEEVA THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Gandeeva Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Jessica L. Rothstein

Resources

Company